Westfield Capital Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.8M | Buy |
3,068,898
+913,761
| +42% | +$29.7M | 0.42% | 69 |
|
|
2025
Q1 | $81.4M | Sell |
2,155,137
-411,622
| -16% | -$15.5M | 0.4% | 71 |
|
|
2024
Q4 | $210M | Buy |
2,566,759
+826,885
| +48% | +$67.7M | 0.91% | 19 |
|
|
2024
Q3 | $199M | Sell |
1,739,874
-189,474
| -10% | -$21.7M | 0.9% | 20 |
|
|
2024
Q2 | $146M | Buy |
1,929,348
+343,253
| +22% | +$25.9M | 0.72% | 27 |
|
|
2024
Q1 | $108M | Buy |
1,586,095
+130,502
| +9% | +$8.91M | 0.57% | 46 |
|
|
2023
Q4 | $91.4M | Buy |
1,455,593
+451,677
| +45% | +$28.4M | 0.53% | 60 |
|
|
2023
Q3 | $51.2M | Buy |
+1,003,916
| New | +$51.2M | 0.35% | 114 |
|